Publication | Closed Access

Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice

NanomedicineEngineeringMedicineNano-drug DeliveryPharmacotherapyDrug Delivery SystemPharmacologyBiomolecular Engineering